Hi-Tech Pharmacal Receives Final Approval for Lorazepam Oral Concentrate Hi-Tech Pharmacal Co., Inc. , a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, granted final approval for the Company's Abbreviated New Drug Application, for Lorazepam oral concentrate 2mg/mL, the generic for Roxanne’s Lorazepam Intensol® oral concentrate which had combined brand and generic sales of $10 million for the 12 months ended December 2011 ...
16 Cleveland High School students test positive for Lorazepam Lorazepam, a drug used to treat anxiety, also known as Ativan, has been confirmed through drug testing as the substance that caused a medical crisis on Tuesday, Jan. 31, at Cleveland High School.
Cleveland: Students were high on Lorazepam; 4 facing charges CLEVELAND, Texas – More than a dozen students who got sick at Cleveland High School Tuesday afternoon were high on Lorazepam, according to CISD. Officials said 16 students took the drug, which is used to treat anxiety and seizures. "That particular drug is really dangerous," said George Youngblood, executive director of Teen and Family Services."They’re in the same drug family as Xanax or Valium ...
CISD: Several Cleveland High students high on Lorazepam rushed to hospital CLEVELAND, Texas – More than a dozen students were treated after possibly overdosing at Cleveland High School Tuesday afternoon, according to a CISD spokesperson. School officials became suspicious when the students got sick after lunch and appeared intoxicated. Ambulances were called to the school and nine students were transported to Cleveland Regional Hospital or Kingwood Hospital. They were ...
FDA approves anxiety drug by Hi-Tech Pharmacal The U.S. Food and Drug Administration has approved Hi-Tech Pharmacal’s generic version of Roxane Laboratories’ Lorazepam Intensol oral concentrate used to treat anxiety. The agency approved Hi-Tech’s Abbreviated New Drug Application. Hi-Tech plans to launch the product by May. Related stories Roxane’s Lorazepam Intensol oral concentrate generated $10 million in branded and generic sales in 2011 ...